Patent · US Active

Methods for detecting symmetrical dimethylarginine

US9970927B2 · kind B2 · utility

7Cited by
4References
75Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2014
Grant dateMay 15, 2018
Priority date
Expiry dateAug 20, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/6812
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Method of detecting Symmetrical dimethyl arginine (SDMA) in biological samples. SDMA analogs for generating anti-SDMA antibodies having little or no cross-reactivity with asymmetrical dimethyl arginine, arginine, and monomethylarginine. The analogs have a protected or free thiol (—SH) group or hydroxyl (—OH) group that allow them to be linked to a suitable conjugation target which can be, for example, a protein containing molecule of a label. The anti-SDMA antibodies can be used in diagnostic immunoassay for the diagnosis of SDMA associated disorders and/or diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.